Toggle light / dark theme

First complete songbird genome exposes missing genes and chromosome architecture

The zebra finch is one of the best-studied songbirds and a model for understanding the biology and neuroscience of vocal learning. Now, researchers have produced the first complete genome assembly of the species, revealing thousands of previously hidden genes and chromosome structures.

Protein ‘switch’ determines whether liposarcoma cells will become aggressive

New research from an expert in cancer biology explains what triggers liposarcoma cells to become more or less aggressive and identifies potential targets that could keep aggressive tumors in check. A study led by Blake Wilde, Ph.D., of Roswell Park Comprehensive Cancer Center highlights how this discovery may pave the way for new treatment options for this cancer.

The findings are published in the journal Science Advances.

More than half of all people with liposarcoma will see their cancer return after treatment, underscoring the need for new and better treatment options. The two most common types of this cancer, which begins in fat tissue, are well-differentiated (WD) and dedifferentiated (DD) liposarcoma, explains the study’s first author, Blake Wilde, Ph.D., assistant professor of oncology in the Departments of Urology and Cell Stress Biology at Roswell Park.

Solving a mysterious inflammatory fever opens the book on a much bigger story

Three research teams working independently around the world have landed on the same discovery: A single molecular “handshake” inside our cells controls a family of inflammatory diseases, including one of the most common inherited fevers on Earth. The finding solved a decades-old puzzle for one family and led to a treatment that worked almost immediately.

It all revolves around Familial Mediterranean Fever (FMF), the most common inherited autoinflammatory disease, which affects an estimated 1–2 in every 1,000 people in high-prevalence populations, including those of Mediterranean, Middle Eastern, Armenian and Jewish ancestry. FMF begins in childhood, causing recurring fevers, painful rashes and joint pain.

For more than 20 years, one family lived with a mysterious illness that resembled FMF, but nothing doctors tried would cure it.

Sixteen AI-designed viruses offer a new route against drug-resistant bacteria

In a world first, scientists led by a team from Stanford University have created 16 viable viruses that do not exist in nature and were designed by AI. Their experiment, which is published in Science, could help in the fight against superbugs by allowing researchers to design customized viruses to kill drug-resistant bacteria. Thomas Inglesby and Moritz S. Hanke have published a Perspective piece on the work and its implications in the same edition of the journal.

Artificial intelligence is already helping to speed up drug discovery by analyzing massive genetic data sets, predicting protein shapes and identifying potential medicines. But in this research, the team wanted to see if AI could go a step further by creating an entire functioning genome based on a natural virus template.

Atomic view of Alzheimer’s disease peptide could inform new drugs

One of the hallmarks of Alzheimer’s disease is the accumulation of a peptide in the brain known as amyloid beta. A new study published in Nature Communications on July 22 has uncovered the atomic structure of the peptide in its harmful form.

Amyloid beta is a naturally occurring peptide that exists in healthy brains. But in Alzheimer’s disease, these peptides clump together abnormally and form large plaques. Scientists have known about the association between these plaques and Alzheimer’s disease for over a century, but whether this buildup is actually damaging the brain or simply a byproduct of the disease has been hotly debated.

There is also an intermediate state of amyloid beta that exists between the healthy peptides and the large plaques. Emerging evidence suggests that it is these intermediates—so-called “oligomeric” amyloid beta—that drive damage to the brain, but their structure has remained unknown. Now, a team of researchers at Yale School of Medicine has characterized this intermediate form for the first time.

Soluble signals released by neighboring cells direct how the human kidney is built

A human kidney is built once, before birth, and the rules guiding its construction have been largely inferred from animal models. Researchers at Penn Medicine have now read those rules directly in human tissue. They found that developing cells are steered by soluble signals released by their neighbors—and identified insulin-like growth factor 2 (IGF2) as a key signal that sustains the kidney’s stem-like cells.

Their study is published in Nature Genetics and was conducted by the Penn-CHOP Kidney Innovation Center, a research collaboration between the Perelman School of Medicine and Children’s Hospital of Philadelphia, working with bioengineers from Penn’s School of Engineering and Applied Science and the Institute for Regenerative Medicine.

How well a kidney is built before birth matters for the rest of a person’s life. Healthy people are born with anywhere from 200,000 to 2 million nephrons—the microscopic filtering units that clear waste from the blood—and no more are made after birth. A low nephron endowment carries a higher lifetime risk of high blood pressure and chronic kidney disease, and severe disruptions of kidney formation are the leading cause of chronic kidney disease in children.